We have recently demonstrated protection against renal ischemic-reperfusion injury in vivo by A 1-and A2a-adenosine receptor (AR) modulations. To further elucidate the signaling cascades of AR-induced cytoprotection against reperfusion/oxidant-mediated injury, immortalized human proximal tubule (HK-2) cells were treated with H 2O2. H2O2 caused dose-and time-dependent HK-2 cell death that was measured by lactate dehydrogenase release and trypan blue dye uptake. Adenosine protected against H 2O2-induced HK-2 cell death by means of A1-and A 2a-AR activation. A1-AR-mediated protection involves pertussis toxin-sensitive G proteins and protein kinase C, whereas A 2a-AR-mediated protection involves protein kinase A activation by means of cAMP and activation of the cAMP response element binding protein. Moreover, protein kinase A activators (forskolin and Sp-isomer cAMP) also protected HK-2 cells against H 2O2 injury. De novo gene transcription and protein synthesis are required for both A 1-and A2a-ARmediated cytoprotection as actinomycin D and cycloheximide, respectively, blocked cytoprotection. Chronic treatments with a nonselective AR agonist abolished the protection by adenosine. Moreover, chronic treatments with a nonselective AR antagonist increased the endogenous tolerance of HK-2 cells against H 2O2. We concluded that A1-and A 2a-AR activation protects HK-2 cells against H2O2-induced injury by means of distinct signaling pathways that require new gene transcription and new protein synthesis. adenosine 3Ј,5Ј-cyclic monophosphate; immortalized human proximal tubule cells; hydrogen peroxide; pertussis toxinsensitive G proteins; protein kinase A; protein kinase C ACUTE RENAL FAILURE SECONDARY to ischemic-reperfusion (I/R) injury continues to be a significant clinical problem (22, 32, 45) . The onset of acute renal failure implies a poor prognosis and is frequently complicated by many other life-threatening complications, including sepsis and multiorgan failure (3, 31, 32) . In high-risk patients undergoing high-risk surgery, the mortality and morbidity rate from perioperative acute renal failure has changed little over the past 30 years (3, 13, 20, 45) .
The A 1 and A 2a adenosine receptors (ARs) serve to protect against I/R injury in many organ systems, including the heart, brain, and kidney (16, (23) (24) (25) (26) 36) . We have recently demonstrated that pre-and postischemic activation of renal A 1 -and A 2a -ARs, respectively, protected renal function against I/R injury in vivo (24) (25) (26) . The in vivo mechanism of preischemic A 1 -AR-mediated renal protection involves pertussis toxin-sensitive G proteins and protein kinase C (PKC), whereas postischemic A 2a -AR-mediated protection is through protein kinase A (PKA) activation by means of cAMP.
There are many limitations in using in vivo models of renal I/R injury to elucidate the detailed signaling cascades of AR-mediated renal cytoprotection. In vivo approaches must deal with multiple cell types within an organ and also with complex physiological control within an animal. In vitro studies with a pure population of a single cell type eliminate these complex external physiological influences and allow the direct study of signaling cascades.
The proximal tubules (especially, the straight, distal portion or S3 segment) located in the outer medulla of the kidney are the primary site of injury in renal ischemia and reperfusion (28, 48) . Immortalized adult human proximal tubular cells (HK-2) have been transfected with E6/E7 genes of human papilloma virus type 16 (41) . Transfection with human papilloma virus type 16 has been shown to immortalize epithelial cells of diverse origin without significantly altering their phenotypes or functions. HK-2 cells have been shown to retain the phenotypic expression and functional characteristics of human proximal tubules (39, 41) . Extensive studies have utilized HK-2 cells to study in vitro renal physiology and pathology (18, 19, 54) . Presently, there are four subtypes of identified ARs (A 1 , A 2a , A 2b , and A 3 ) (12) . We have recently verified the presence of all four subtypes of ARs and demonstrated several key signaling intermediates in HK-2 cells (26a) .
There are few studies of in vitro renal cell protection with AR modulations. Adenosine protected against hypoxia-reoxygenation injury in a porcine kidney cell line (LLC-PK 1 ) by means of an A 2a -AR3 cAMP-medi-ated mechanism (52) . However, AR-mediated protection in a human renal cell line has not been reported to date. In this study, we injured HK-2 cells with H 2 O 2 . Oxygen free radicals with resultant oxidant tissue stress are a key mediator of renal reperfusion injury (15, 37) . During reperfusion after ischemia, reactive oxygen species, such as superoxide anion, hydroxyl radical, and H 2 O 2 , are generated. These reactive oxygen species cause lipid peroxidation of the renal cell membrane, with a resultant intracellular calcium overload and subsequent necrotic cell death (37, 42, 43) . We hypothesized that as we observed in vivo, A 2a -AR activation would protect against oxidant-mediated injury in human renal cells. We also aimed to determine the signaling pathways of AR-mediated protection against oxidant injury in HK-2 cells.
MATERIALS AND METHODS

HK-2 Cell Culture
HK-2 cells (American Type Culture Collection, Manassas, VA) were grown and passaged in 75-cm 2 cell culture flasks containing culture medium (keratinocyte serum-free medium ϩ 5 ng/ml epidermal growth factor and 40 mg/ml bovine pituitary extract) and antibiotics (100 U/ml of penicillin G, 100 g/ml of streptomycin, and 0.25 g/ml of amphotericin B) at 37°C in a 100% humidified atmosphere of 5% CO 2-95% air. They were plated in 6-or 24-well plates when 80% confluent and used in the experiments described in Specific Protocols when confluent.
Methods for Inducing Oxidant Injury: H2O2-Induced Injury for HK-2 Cells
Oxidant injury in HK-2 cells was induced with H2O2. After indicated pretreatments (e.g., with AR agonists or with vehicle), confluent monolayers of HK-2 cells grown in 6-or 24-well plates were treated with H 2O2 diluted in serum-free media for 1-3 h.
Measurement of Cell Viability and Cell Death
Cell viability assays were performed by using the trypan blue dye exclusion method. After the treatment protocols (e.g., H2O2 Ϯ AR agonists), cells were trypsinized and stained with 0.4% trypan blue dye for 5 min. The proportion of cells remaining nonviable (unable to exclude trypan blue) was counted by using a hemocytometer. The number of cells remaining nonviable was expressed as a percentage of the total number of cells.
Lactate dehydrogenase (LDH) released into the media was also measured as a marker of cellular injury by using a commercially available colorimetric method (Sigma, St. Louis, MO). In some experiments, LDH released into the media was expressed as the percentage of total cellular LDH per well measured after the cells were lysed with 1% Triton X. Otherwise, LDH release after the various treatment protocols (e.g., H 2O2 Ϯ AR agonists) was expressed as the percentage of the LDH release by the H2O2 group within the same experiment.
Immunoblot Analyses
We measured activation of cAMP response element binding (CREB) proteins in HK-2 cells by immunoblotting with antibodies to the phosphorylated forms of CREB. The HK-2 cells in 6-well plates were washed twice with Hanks' balanced salt solution and scraped with 100 l of calcium-free Hanks' balanced salt solution plus protease inhibitors (2 g/ml leupeptin and 2 g/ml aprotinin). Aliquots were used for protein assay, and the remainder were mixed with an equal volume of sample buffer (62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol, and 5% ␤-mercaptoethanol, final concentration). Twenty to forty micrograms of each sample were electrophoresed at room temperature through discontinuous 10% SDS-polyacrylamide gels at 80 V for 4 h and subjected to immunoblot analysis as described previously (17) . The primary polyclonal antibody for phospho-CREB (New England Biolabs) was diluted 1:1,000 in Tris-buffered saline-0.1% Tween 20 containing 1% nonfat dry milk and 0.02% sodium azide. The secondary antibody (goat anti-rabbit IgG conjugated to horseradish peroxidase at 1:5,000 dilution) was detected with enhanced chemiluminescence immunoblotting detection reagents (Amersham), with subsequent exposure to autoradiography film. The intensities of the immunoblots were quantified with a scanner coupled to a personal computer with MacBas 2.2 software.
Up-and Downregulation of ARs in HK-2 Cells
We have previously demonstrated that treatment for 48 h with a nonselective AR antagonist, 8-phenyltheophylline (8-PT), upregulated A 1-and A2a-ARs, whereas 48-h treatment with a nonselective AR agonist 5Ј-N-ethylcarboxamidoadenosine (NECA), downregulated all four subtypes of ARs (26a). When confluent, HK-2 cells grown in 6-or 24-well plates were incubated with 100 M of nonselective AR antagonist 8-PT or 10 M of nonselective agonist NECA for 48 h in complete cell culture media.
Protein Determination
Protein content was determined with the Pierce Chemical (Rockford, IL) bicinchoninic acid protein assay reagent with BSA as a standard.
Specific Protocols
We first determined the protective roles of adenosine and AR subtype-specific agonists against H 2O2-mediated oxidant injury in HK-2 cells.
H 2O2-induced injury. HK-2 cells in serum-free cell culture media were subjected to 1-3 h of 2, 5, and 10 mM H2O2. [The 1-h time point was chosen for the subsequent studies with 5 mM of H 2O2 as this time and dose of H2O2-induced moderate (ϳ50-60%) cellular injury.]
Adenosine before H 2O2-induced injury. HK-2 cells were incubated with 1-100 M of adenosine for 30 min in serumfree cell culture media and then subjected to 1 h of 5 mM H 2O2 injury.
Selective AR agonists before H2O2-induced injury. HK-2 cells were incubated with 1 nM-10
, highly selective A1-, A2a-, and A3-AR agonists, respectively, for 30 min in serum-free cell culture media and then subjected to 1 h of 5 mM H2O2 injury.
Selective AR antagonists before adenosine. HK-2 cells were incubated with 1-10 M of 1,3-dipropyl-8-cyclopentylxanthine, 8-(3-chlorostyryl)caffeine, or 9-chloro-2-(2-fury) [1, 2, 4] triazolo [1,5- c]quinazolin-5-phenylacetamide, highly selective A 1-, A2a-, and A3-AR antagonists, respectively, for 30 min in serum-free cell culture media before 30 min of 100 M adenosine followed by 1 h of 5 mM H 2O2 injury.
We have previously described that PKC and pertussis toxin-sensitive G proteins (G i/o) play important roles in signal transduction of A1-AR-mediated renal protection in vivo (24) . To determine the potential roles of Gi/o and PKC in adenosine-mediated protection against oxidant injury, HK-2 cells were subjected to the following protocols.
Adenosine or selective AR agonists ϩ pertussis toxin before H 2O2-induced injury. HK-2 cells were pretreated with 100 ng/ml pertussis toxin for 14 h before adenosine or selective A 1-, A2a-, or A3-AR agonist treatment followed by 1 h of 5 mM H2O2 injury.
PKC antagonist before adenosine or AR agonists. HK-2 cells were incubated with 100 nM of GF-109203X, a highly selective PKC antagonist, for 30 min in serum-free cell culture media before adenosine or selective A 1-, A2a-, or A3-AR agonist treatment followed by 1 h of 5 mM H2O2 injury.
The A2a-ARs in HK-2 cells couple to adenylyl cyclase to activate the cAMP and PKA pathway (26a) . In addition, we demonstrated that A 2a-ARs protect against reperfusion injury in vivo by means of activation of PKA by cAMP (26) . To determine the potential roles of PKA and cAMP in adenosineinduced protection against oxidant injury, HK-2 cells were subjected to the following protocols.
PKA antagonist before adenosine or AR agonist. HK-2 cells were incubated with 100 M of Rp-isomer (Rp)-cAMP for 30 min in serum-free cell culture media before adenosine or selective A 1-, A2a-, or A3-AR agonist treatment followed by 1 h of 5 mM H2O2 injury.
PKA agonist instead of adenosine. HK-2 cells were incubated with 100 M of Sp-isomer (Sp)-cAMP for 30 min in serum-free cell culture media before 1 h of 5 mM H 2O2 injury.
To determine the roles for new gene transcription and new protein synthesis in adenosine-induced renal protection against oxidant injury, HK-2 cells were subjected to the following protocols.
Actinomycin D before adenosine. HK-2 cells were incubated with 10 g/ml actinomycin D, an inhibitor of new gene transcription, for 60 min in serum-free media before 30 min of 100 M adenosine followed by 1 h of 5 mM H 2O2 injury.
Cycloheximide before adenosine. HK-2 cells were incubated with 10 g/ml cycloheximide, an inhibitor of new protein synthesis, for 60 min in serum-free media before 30 min of 100 M adenosine followed by 1 h of 5 mM H 2O2 injury.
After these treatment protocols, cell injury was quantified by measuring cellular release of LDH and trypan blue dye exclusion.
Materials
Adenosine was dissolved in saline. All other drugs were dissolved first in DMSO and then further diluted in water such that the final concentration of DMSO in each experimental condition was Ͻ0.01%. Solutions were made daily. All chemicals used were of the purest analytical grade and obtained from Sigma.
Statistics and Data Analysis
The data were analyzed with Student's t-test when means between two groups were compared or with one-way analysis of variance plus Dunnett's post hoc multiple comparison test to compare mean values across multiple treatment groups.
RESULTS
H 2 O 2 Injures HK-2 Cells
Exogenous H 2 O 2 was used to induce free radicalmediated oxidant injury in HK-2 cells. 
Adenosine Protects Against H 2 O 2 Injury
Figures 2 and 3 show that adenosine pretreatment for 30 min significantly protects against H 2 O 2 -mediated cell death. With 100 M of adenosine pretreatment, significantly less LDH (66.7 Ϯ 5.3% of 5 mM H 2 O 2 -alone treated group, n ϭ 6, P Ͻ 0.05; Fig. 2 ) was released into the cell culture media and more cells excluded trypan blue dye (6.1ϩ0.9% trypan blue-positive cells vs. 14.8 Ϯ 1.1% for 5 mM H 2 O 2 -alone-treated group, n ϭ 6, P Ͻ 0.05; Fig. 3) . 1-h incubation, n ϭ 3; B) manner. Cell injuries were quantified by measuring the percentage of total cellular lactate dehydrogenase (LDH) released into the culture media after a specified incubation period and dose. Catalase (9,000 U/ml) prevented HK-2 cell death after H2O2. Error bars, SE.
injury. The LDH release in 10 M R-PIA-and 10 M CGS-21680-pretreated HK-2 cells was 78.6 Ϯ 3.1% (n ϭ 15, P Ͻ 0.05) and 67.7 Ϯ 3.6% (n ϭ 18, P Ͻ 0.05) of the H 2 O 2 -alone-treated group. Similar results were observed for trypan blue uptake when investigators were blinded to experimental conditions. The trypan blue uptake of R-PIA (9.3 Ϯ 0.2%, n ϭ 6)-and CGS-21680-treated (5.1 Ϯ 0.5%, n ϭ 6) cells was also significantly reduced compared with the H 2 O 2 -alone-treated group (14.8 Ϯ 1.1%, n ϭ 6, P Ͻ 0.05; Fig. 3 ). The A 3 -AR agonist IB-MECA (10 M) failed to protect against oxidant injury (LDH release of 115.3 Ϯ 5.4% of the H 2 O 2 -alone-treated group, n ϭ 12).
A 1 -ARs Protect Via G i/o and PKC Pathway
We utilized specific inhibitors of G i/o proteins and PKC to determine the involvement of these signaling intermediates in A 1 -and A 2a -AR-mediated protection against oxidant injury. Pertussis toxin treatment (100 ng/ml, 14 h) or pretreatment for 30 min with a PKC inhibitor (GF-109203X, 100 nM) blocked A 1 -AR agonist (10 M R-PIA)-mediated protection against H 2 O 2 (LDH ϭ 105.6 Ϯ 8.0%, n ϭ 6, and LDH ϭ 97.4 Ϯ 3.6%, n ϭ 6, of H 2 O 2 -alone-treated group, respectively; Fig.  5A ). However, pertussis toxin and GF-109203X failed to block A 2a -AR agonist (10 M CGS-21680)-mediated protection against oxidant injury (LDH ϭ 75.0 Ϯ 6.4%, n ϭ 6, and LDH ϭ 79.9 Ϯ 2.7%, n ϭ 6, of H 2 O 2 -alonetreated group, respectively; Fig. 5A) .
A 2a -ARs Protect Via cAMP3 PKA Pathway
The A 2a -AR-mediated cytoprotection against oxidant injury involves adenylyl cyclase activation and gener- ation of cAMP to stimulate PKA, because the PKA agonist Sp-cAMP (100 M, 30-min pretreatment) and the PKA antagonist Rp-cAMP (100 M, 30-min pretreatment) mimicked and blocked, respectively, the A 2a -AR agonist-induced protection against oxidant injury (LDH ϭ 57.9 Ϯ 6.3%, n ϭ 6, and LDH ϭ 91.0 Ϯ 3.2%, n ϭ 6, of H 2 O 2 -alone-treated group, respectively; Fig. 5B) . A 1 -AR-mediated cellular protection was not blocked by Rp-cAMP. Moreover, forskolin (10 M, 30-min pretreatment), an agonist that increases cAMP levels, mimicked the cytoprotection provided by the A 2a -AR agonist (LDH ϭ 69.8 Ϯ 6.7%, n ϭ 6; Fig. 5B ).
Upregulation of A 1 -and A 2a -ARs Modulates Protection Against H 2 O 2
We have previously demonstrated that treatment for 48 h with a nonselective AR antagonist (8-PT) upregulated A 1 -(ϳ1.9-fold) and A 2a -(ϳ1.5-fold) ARs, whereas 48-h treatment with a nonselective AR agonist (NECA) downregulated all four subtypes of ARs (26a) . In this study, we demonstrate that chronic treatments with a nonselective AR antagonist conferred significant endogenous protection against oxidant injury (Fig. 6) . After 48 h of treatment with 8-PT, 5 mM H 2 O 2 killed significantly fewer HK-2 cells (LDH ϭ 50.5 Ϯ 3.1% of H 2 O 2 group, n ϭ 6). Conversely, chronic NECA treatment significantly attenuated the protection by 100 M adenosine pretreatment (LDH ϭ 90.8 Ϯ 1.2%, n ϭ 6).
Role of CREB in Oxidant Injury
We have previously demonstrated the expression of both phosphorylated (activated) and nonphosphorylated forms of CREB in HK-2 cells (26a). Oxidant injury with H 2 O 2 significantly decreased the phosphorylated (activated) form of CREB. The A 2a -AR agonist (CGS-21680) and Sp-CAMP rescued the decreased phosphorylation of CREB induced by H 2 O 2 . Activation of the CREB transcription factor correlates with cytoprotection by the A 2a -AR agonist and Sp-CAMP (Fig. 7) .
Role of New Gene Transcription and Protein Synthesis in Adenosine-Induced Cytoprotection
Actinomycin D and cycloheximide blocked the protection by the A 1 -AR agonist (LDH ϭ 98.9 Ϯ 7.5, n ϭ 6, and 101.4 Ϯ 4.7, n ϭ 4, respectively, of the H 2 O 2 -alone- Fig. 6 . Chronic pretreatment with a nonselective AR antagonist 8-phenyltheophylline (8-PT), 100 M for 48 h, known to increase expression of A1-(ϳ1.9-fold) and A2a-(ϳ1.5-fold) ARs (26a) resulted in endogenous protection against acute H2O2 injury (n ϭ 6). Conversely, chronic pretreatment with a nonselective AR agonist [5Ј-Nethylcarboxamidoadenosine (NECA), 10 M for 48 h, known to decrease expression of all 4 subtypes of ARs] significantly attenuated the cytoprotective effect of acute adenosine (100 M for 30 min, n ϭ 6). Cell injuries were quantified by measuring LDH released into the culture media after addition of 5 mM H2O2 for 1 h compared with LDH released by the H2O2 group. Error bars, SE. *P Ͻ 0.05 vs. H2O2-alone group; #P Ͻ 0.05 vs. vehicle-treated acute adenosine treatment group. treated group), the A 2a -AR (LDH ϭ 97.3 Ϯ 2.3, n ϭ 6, and 104.6 Ϯ 2.9, n ϭ 3, respectively) agonist, and Sp-CAMP (LDH ϭ 100.2 Ϯ 2.6, n ϭ 6, and 103.2 Ϯ 5.8, n ϭ 3, respectively), indicating that new transcription and protein synthesis, respectively, are required for A 1 -and A 2a -AR-mediated protection against H 2 O 2 oxidant injury (Fig. 8 ).
DISCUSSION
Adenosine protects against H 2 O 2 -mediated oxidant injury in HK-2 cells by means of both A 1 -and A 2a -AR activation. The A 1 -AR-mediated protection involves PKC by means of pertussis toxin-sensitive G proteins (G i/o ), whereas the A 2a -AR-mediated protection is by means of PKA activation by cAMP. Our findings complement our previous studies in which differential AR modulations protected against global renal I/R injury in vivo (24) (25) (26) .
The detrimental effect of renal I/R injury that results in acute renal failure is a serious and unresolved clinical challenge (47) . Surgical procedures involving the aorta and renal arteries (e.g., supra-and juxtarenal abdominal aortic aneurysms and renal transplantation, in particular) display significant postoperative renal complications in the form of acute tubular necrosis and acute renal failure (3, 31, 32) . Although ischemia can cause renal cell death and injury, significant renal tubular and vascular damage develop during the reperfusion period secondarily to oxygen free radicalmediated cellular injury (2, 34) . Oxygen free radicals are considered to be important mediators of reperfusion injury, because reperfusion of a previously ischemic kidney results in robust generation of oxygen free radicals (34) . H 2 O 2 is formed in mitochondria as a dismutation product of the superoxide radical (O 2 Ϫ ) under physiological conditions. However, under ischemic stress, there is proteolytic modification of xanthine dehydrogenase to xanthine oxidase, which effectively produces a profoundly increased burst of O 2 Ϫ and H 2 O 2 when oxygen is reintroduced during reperfusion. H 2 O 2 and its far more toxic metabolite, the hydroxyl radical, contribute significantly to renal injury during reperfusion. Cytotoxic oxidant free radicals produce cellular lipid peroxidation, cytotoxic enzyme activation, impaired energy metabolism, protein oxidation, and a massive rise in intracellular Ca 2ϩ concentration (34, 43) .
Renal cells with proximal tubular characteristics, including LLC-PK 1 (pig), NHK-C (human), and opossum kidney cells, are much more susceptible to oxidant-reperfusion injury than those with distal tubular characteristics (Madin-Darby canine kidney cells) (50, 51) . In this study, we utilized H 2 O 2 -mediated oxidant injury as an in vitro model of reperfusion injury. In initial pilot studies, our attempt to produce in vitro hypoxia-reoxygenation injury by using a hypoxic chamber was unsuccessful. Incubation (24 h) in a 95% N 2 -5% CO 2 chamber followed by reoxygenation failed to produce significant HK-2 cell death measured by LDH release (26a) . Epithelial cells such as HK-2 can utilize amino acid by means of gluconeogenesis to produce glucose and, therefore, are not susceptible to hypoxic cell death. Moreover, achieving true anoxia by removing O 2 from the cell culture environment is often im- practical. Many in vivo and in vitro models of renal oxidant injury utilized exogenous application of oxygen free radicals such as H 2 O 2 or t-butylhydroperoxide to mimic the free radical-mediated injury of reperfusion (29, 53) .
The proximal tubules (especially, the straight, distal portion or S3 segment) located in the outer medulla of the kidney are the primary site of injury in renal ischemia and reperfusion (28, 48) . This region is marginally oxygenated under normal physiological conditions, with a high basal metabolic demand (11, 28) . Therefore, with hypoxic or ischemic insult, proximal tubules in the outer medullary zone suffer the most damage.
To show that HK-2 cells are a valid cellular model to study adenosine-mediated protection of renal proximal tubule cells, we have demonstrated that HK-2 cells express all four subtypes (A 1 , A 2a , A 2b , and A 3 ) of ARs and display key signaling intermediates, including several PKC isoforms (␣, ␦, and ⑀), G proteins (G i , G s , and G q ), and mitogen-activated protein kinases [extracellular signal-regulated kinase (ERK)1/2, c-Jun NH 2 -terminal kinase, and p38] (26a). We also verified that A 1 -and A 3 -ARs inhibit forskolin-stimulated adenylyl cyclase activity and that A 2a -ARs stimulate adenylyl cyclase activity. In addition, chronic (48-h) antagonist (8-PT) and agonist (NECA) treatment led to up-and downregulation of various ARs and G protein subtypes.
Adenosine has cytoprotective effects in several cell types, including renal cells (5, 10) . AR activation, specifically the A 1 and A 2a subtypes, attenuates several factors responsible for generating I/R injury (27, 38, 49) . A 1 -AR activation attenuates I/R injury when given before the ischemic insult in cerebral (38) , cardiac (9, 49) , and renal (25) cells and has been implicated to mediate ischemic preconditioning. Conversely, postischemic A 2a -AR also protects against tissue injury by attenuating the reperfusion phase of the injury process in pulmonary (1), cardiac (7) , and renal cells (26) .
In this study, we demonstrated that both A 1 -and A 2a -AR agonists protected against the direct cytotoxic effects of H 2 O 2 (nonreceptor-mediated cytotoxicity) by means of distinct receptor-mediated cellular mechanisms in HK-2 cells. We demonstrated in this study that A 2a -ARs, by means of cAMP-dependent mechanisms, protected HK-2 cells against H 2 O 2 -mediated cell death. The A 2a -AR-mediated protection from H 2 O 2 injury was blocked by Rp-cAMP, an inhibitor of PKA. Additionally, agents that increase cAMP, isoproterenol and forskolin, or direct activation of PKA by Sp-cAMP also protected against H 2 O 2 -induced cell injury. These in vitro results agree with in vivo results previously described in which A 2a -AR activation protected against renal I/R injury in vivo (26, 35) . Stimulation of A 2a -ARs, including those present in renal tubule cells and vasculature, results in increased cellular cAMP to activate PKA (4, 40) . Our study agrees with previous studies that suggest that increased intracellular cAMP protects against renal reoxygenation-oxidant injury in vivo (6) and in vitro (21, 52) . Our study also agrees with previous studies showing that agents that increase intracellular cAMP also attenuate reperfusion injury in the heart, lung, and kidney in vivo and in vitro (8, 44) .
After oxidant injury, CREB activity decreased significantly. We have previously demonstrated in HK-2 cells that A 2a -ARs activate CREB via cAMP-and PKAdependent pathways (26a). Moreover, improved preservation of HK-2 CREB activity after A 2a -AR activation or with Sp-cAMP correlates with improved cellular survival after H 2 O 2 -mediated injury. We propose that increased HK-2 cell survival and activation of CREB is one of the potential mechanistic links after A 2a -AR activation by means of cAMP and PKA.
We also demonstrated that activation of A 1 -ARs in HK-2 cells also protects against H 2 O 2 -induced cellular injury via signaling pathways involving PKC and G i/o proteins. This was shown by attenuating the protection induced by the A 1 -AR agonist R-PIA with pertussis toxin and GF-109203X. These findings agree with our previous in vivo studies in which both G i/o and PKC were intermediates in A 1 -AR-mediated protection of renal I/R injury (24) . This study agrees with heart studies in which A 1 -ARs are involved in protection against H 2 O 2 -induced oxidative injury in vivo and in vitro (33, 46) by modulation of the detrimental increases in intracellular calcium concentration and by means of activation of cardiomyocyte K ATP channels after H 2 O 2 exposure (14, 46) . After exposure to H 2 O 2 , intracellular ATP decreases significantly (ϳ30% of baseline, data not shown), and the A 1 -AR activation may attenuate this component of cellular injury. Therefore, whereas the A 2a -ARs attenuate the free radical-mediated cellular injury (e.g., lipid peroxidation and membrane damage), the A 1 -ARs may attenuate the cellular injury caused by a lethal drop in intracellular ATP.
In summary, this is the first report of an in vitro protective effect of adenosine in HK-2 cells by means of A 1 -and A 2a -AR activation. We have systematically deciphered the signal pathways of A 1 -and A 2a -ARmediated renal cytoprotection. These findings have potentially profound clinical significance in the protection of the kidney in the perioperative care of patients subjected to renal ischemia.
